ITMI20040218A1 - Uso di neridronato sodico per promuovere la neoformazione ossea - Google Patents

Uso di neridronato sodico per promuovere la neoformazione ossea

Info

Publication number
ITMI20040218A1
ITMI20040218A1 IT000218A ITMI20040218A ITMI20040218A1 IT MI20040218 A1 ITMI20040218 A1 IT MI20040218A1 IT 000218 A IT000218 A IT 000218A IT MI20040218 A ITMI20040218 A IT MI20040218A IT MI20040218 A1 ITMI20040218 A1 IT MI20040218A1
Authority
IT
Italy
Prior art keywords
nerhydronate
sodium
promote bone
bone neoformation
neoformation
Prior art date
Application number
IT000218A
Other languages
English (en)
Inventor
Silvano Adami
Sergio Rosini
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Priority to IT000218A priority Critical patent/ITMI20040218A1/it
Publication of ITMI20040218A1 publication Critical patent/ITMI20040218A1/it
Priority to PCT/EP2005/001293 priority patent/WO2005074944A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT000218A 2004-02-10 2004-02-10 Uso di neridronato sodico per promuovere la neoformazione ossea ITMI20040218A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000218A ITMI20040218A1 (it) 2004-02-10 2004-02-10 Uso di neridronato sodico per promuovere la neoformazione ossea
PCT/EP2005/001293 WO2005074944A1 (en) 2004-02-10 2005-02-09 Use of sodium neridronate to promote new bone formation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000218A ITMI20040218A1 (it) 2004-02-10 2004-02-10 Uso di neridronato sodico per promuovere la neoformazione ossea

Publications (1)

Publication Number Publication Date
ITMI20040218A1 true ITMI20040218A1 (it) 2004-05-10

Family

ID=34835584

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000218A ITMI20040218A1 (it) 2004-02-10 2004-02-10 Uso di neridronato sodico per promuovere la neoformazione ossea

Country Status (2)

Country Link
IT (1) ITMI20040218A1 (it)
WO (1) WO2005074944A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106794190A (zh) * 2014-10-15 2017-05-31 埃比奥吉恩药物股份公司 奈立膦酸或其盐用于治疗骨关节炎的用途
IT201900008391A1 (it) * 2019-06-07 2020-12-07 Abiogen Pharma Spa Procedimento di preparazione del polimorfo f di sodio neridronato

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
FI92465C (fi) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
DK1365769T3 (da) * 2001-02-06 2011-05-16 Sydney Children S Hospitals Network Randwick And Westmead Incorporating The Royal Alexandra Hospital Lægemiddel til behandling af osteonekrose og til behandling af patienter med risiko for at udvikle osteonekrose
US20040157798A1 (en) * 2001-04-03 2004-08-12 Little David Graham Drug for use in bone grafting
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone

Also Published As

Publication number Publication date
WO2005074944A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
LTPA2017004I1 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
DE502006009254D1 (de) Herstellung von natriumdiformiat
IS7357A (is) Notkun bensóþíasepíns með tálmvirkni gegn flutningi gallsýru í dausgörn til að draga úr kólesterólhækkun
DK1720866T3 (da) Fremgangsmåde
IS8316A (is) Notkun kalsítóníns við slitgigt
MA28880B1 (fr) Forme thermodynamiquement stable de tosylate de bay 43-9006
ATE432056T1 (de) Zervikale zwischenwirbelprothese
ITMI20050191A1 (it) Struttura di fet ad alette
ITCO20050028A1 (it) Complesso di acceleratori di protoni in particolare per uso medicale
BRPI0813105A2 (pt) Derivado de sulfonamida de ácido malônico e uso faramacêutico do mesmo
CL2007002837A1 (es) Uso de fenitoina para tratar mucositis oral.
NO20055643D0 (no) Preparation of lodixanol
JP2006502186A5 (ja) β-グルカンの使用
NO20043305D0 (no) Preparation of lodixanol
ITMI20051416A1 (it) Composizioni cosmetiche contenenti acido ialuronico e colostro
DE112004001799D2 (de) Tensidhaltiger Knochenzement
ITMI20040218A1 (it) Uso di neridronato sodico per promuovere la neoformazione ossea
ITPS20030026A1 (it) Struttura di osteotomo.
ATA14002004A (de) Pumpfähiger selbstnivellierender magnesiaestrich
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
ITMI20042139A1 (it) Procedimento per la produzione di cefepime e cefaposporine analoghe
FR2877833B1 (fr) Correcteur de lordoses
ITMI20042099A1 (it) Estratti di trifoglio per la preparazione di agenti anti-afidi
ITMI20041086A1 (it) Procedimento per la preparazione di idrocarbilalogenuri
FR2870110B1 (fr) Prothese de refection anatomique